Artículos con órdenes de acceso público - MakMás información
No disponibles en ningún lugar: 22
Revisar
The p53 family: guardians of maternal reproduction
AJ Levine, R Tomasini, FD McKeon, TW Mak, G Melino
Nature reviews Molecular cell biology 12 (4), 259-265, 2011
Órdenes: US National Institutes of Health
Revisar
Lipocalin‐2 (NGAL) attenuates autophagy to exacerbate cardiac apoptosis induced by myocardial ischemia
HK Sung, YK Chan, M Han, JWS Jahng, E Song, E Danielson, T Berger, ...
Journal of Cellular Physiology 232 (8), 2125-2134, 2017
Órdenes: Heart and Stroke Foundation of Canada
Revisar
Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver
A Asimakopoulou, E Borkham-Kamphorst, M Henning, E Yagmur, ...
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2014
Órdenes: German Research Foundation
Revisar
Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex
L Wang, D Opland, S Tsai, CT Luk, SA Schroer, MB Allison, AJ Elia, ...
Nature Medicine 20 (5), 484-492, 2014
Órdenes: US National Institutes of Health, Canadian Institutes of Health Research
Revisar
Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model
T Berger, T Ueda, E Arpaia, IIC Chio, EA Shirdel, I Jurisica, K Hamada, ...
Oncogene 32 (41), 4989-4994, 2013
Órdenes: Canadian Institutes of Health Research
Revisar
Check point inhibitors as therapies for infectious diseases
MA Cox, R Nechanitzky, TW Mak
Current Opinion in Immunology 48, 61-67, 2017
Órdenes: Canadian Institutes of Health Research
Revisar
Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo
J Asano, H Tada, N Onai, T Sato, Y Horie, Y Fujimoto, K Fukase, A Suzuki, ...
The journal of immunology 184 (2), 736-745, 2010
Órdenes: US National Institutes of Health
Revisar
Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides
R Laufer, G Ng, Y Liu, NKB Patel, LG Edwards, Y Lang, SW Li, M Feher, ...
Bioorganic & medicinal chemistry 22 (17), 4968-4997, 2014
Órdenes: Canadian Institutes of Health Research
Revisar
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation
IIC Chio, M Sasaki, D Ghazarian, J Moreno, S Done, T Ueda, S Inoue, ...
Nature cell biology 14 (6), 625-633, 2012
Órdenes: Canadian Institutes of Health Research
Revisar
Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions
K Labbus, M Henning, E Borkham-Kamphorst, C Geisler, T Berger, ...
Journal of proteomics 78, 188-196, 2013
Órdenes: German Research Foundation
Revisar
Design and optimization of (3-aryl-1H-indazol-6-yl) spiro [cyclopropane-1, 3′-indolin]-2′-ones as potent PLK4 inhibitors with oral antitumor efficacy
SW Li, Y Liu, PB Sampson, NK Patel, BT Forrest, L Edwards, R Laufer, ...
Bioorganic & Medicinal Chemistry Letters 26 (19), 4625-4630, 2016
Órdenes: Canadian Institutes of Health Research
Revisar
Promoting immunity during chronic infection—the therapeutic potential of common gamma-chain cytokines
JG Toe, M Pellegrini, TW Mak
Molecular immunology 56 (1-2), 38-47, 2013
Órdenes: National Health and Medical Research Council, Australia, Canadian Cancer Society
Revisar
Bcl10/Malt1 signaling is essential for TCR-induced NF-κB activation in thymocytes but dispensable for positive or negative selection
PJ Jost, S Weiss, U Ferch, O Gross, TW Mak, C Peschel, J Ruland
The Journal of Immunology 178 (2), 953-960, 2007
Órdenes: German Research Foundation
Revisar
Discovery of 4-(4-aminopyrazolo [1, 5-a][1, 3, 5] triazin-8-yl) benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK
R Laufer, SW Li, Y Liu, G Ng, Y Lang, M Feher, R Brokx, I Beletskaya, ...
Bioorganic & medicinal chemistry letters 26 (15), 3562-3566, 2016
Órdenes: Canadian Institutes of Health Research
Revisar
Illuminating the cross-talk between tumor metabolism and immunity in IDH-mutated cancers
J Leca, J Fortin, TW Mak
Current opinion in biotechnology 68, 181-185, 2021
Órdenes: Canadian Institutes of Health Research
Revisar
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells
K Sugata, Y Matsunaga, Y Yamashita, M Nakatsugawa, T Guo, ...
Nature Biotechnology 39 (8), 958-967, 2021
Órdenes: Natural Sciences and Engineering Research Council of Canada, Ontario …
Revisar
FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients
Y Han, J Cui, Y Lu, S Sue, E Arpaia, TW Mak, MD Minden
Leukemia Research 36 (11), 1339-1346, 2012
Órdenes: Canadian Institutes of Health Research, Ontario Institute for Cancer Research
Revisar
Checkpoint kinase Chk2 controls renal Cyp27b1 expression, calcitriol formation, and calcium-phosphate metabolism
H Fahkri, B Zhang, A Fajol, N Hernando, B Elvira, JG Mannheim, ...
Pflügers Archiv-European Journal of Physiology 467, 1871-1880, 2015
Órdenes: German Research Foundation
Revisar
DJ‐1/Park7 Sensitive Na+/H+ Exchanger 1 (NHE1) in CD4+ T Cells
Y Zhou, X Shi, H Chen, S Zhang, MS Salker, AF Mack, M Föller, TW Mak, ...
Journal of cellular physiology 232 (11), 3050-3059, 2017
Órdenes: German Research Foundation
Revisar
TREM-2 mediates dendritic cell–induced NO to suppress Th17 activation and ameliorate chronic kidney diseases
CC Lin, TY Chang, YC Lu, YS Wu, W Huang, WC Lo, GF Liu, WC Hsu, ...
Journal of Molecular Medicine 100 (6), 917-931, 2022
Órdenes: Canadian Institutes of Health Research
La información de publicación y financiación se determina de forma automática mediante un programa informático